Adjusting to change in healthcare: Learning from translational research

Martine Leroy|30th March 2016

Healthcare is undergoing a transformative change, which presents challenges to all players in the sector. Factors of change include evolving expectations and requirements from populations and governments, and newcomers to the field that are changing both supply and demand. Established healthcare players like pharma need to control and shape their emerging roles.

In this respect, pharma needs to be more pro-active if it is to strengthen and enhance its role. Its efforts to date seem quite timid.

Translational research organisations are healthcare players who are adjusting their strategies in anticipation of change, thus turning challenges into opportunities. What if pharma learned how to adapt faster and more effectively from these organisations?

Head of Insight Martine Leroy explores this ‘what if’ scenario, outlining the ways that pharma could learn from translational research organisations and improve their approach to the changing healthcare landscape.

Translational research organisations are adjusting their strategy

In the UK, the National Health System (NHS) is a major factor of change in that it places engagement and responsibility of the population in their own health and care at the centre of its policy. This is focusing the transformation of the healthcare landscape on cost-effective, positive patient outcomes. Translational research organisations are responding by adjusting their strategies to align with the NHS, to contribute to delivering better patient outcomes, faster.

Traditionally, the role of translational research is to increase the volume of basic scientific discovery that goes into clinical research and hopefully, become real clinical innovation. This is because historically, there is a waste of basic scientific learning that goes into clinical research, because of lack of focus and funding, amongst other factors. 

 

Download the full article by clicking the button below.

Designing a global digital patient services platform

Elisa del Galdo|22nd January 2020

Within our customer experience capability at Blue Latitude Health, our UX researchers and designers are tasked with understanding customer and client needs. Recently, a client required a centralised system to drive the development and deployment of data-driven patient services. Here, we explain the process of developing this platform.

read more

Digital therapeutics and their impact on society

Elisa del Galdo|14th January 2020

Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?

read more

Life with multiple myeloma - why I'm a lucky man living the dream

Guest Blogger|18th December 2019

Multiple myeloma patient Bob Munro explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from London to the Arc de Triomphe.

read more